Cargando…

Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients

PURPOSE: To quantify changes in tear break-up time (TBUT), corneal staining and ocular surface disease index (OSDI) in glaucoma patients after switching therapy from latanoprost with 0.02% benzalkonium chloride (BAK) to travoprost with sofZia(™). METHODS: Prospective consecutive case series evaluati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horsley, Michael B, Kahook, Malik Y
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709012/ https://www.ncbi.nlm.nih.gov/pubmed/19668581

Ejemplares similares

Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2014)

Ocular Surface Cytotoxicity and Safety Evaluation of Tafluprost, a Recently Developed Anti-Glaucoma Prostaglandin Analog
por: Niwano, Yoshimi, et al.
Publicado: (2014)

Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review
por: Takagi, Yasutaka, et al.
Publicado: (2018)

In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study
por: Kim, Jee Hyun, et al.
Publicado: (2015)

Influence of BAK-Preserved Prostaglandin Analog Treatment on the Ocular Surface Health in Patients with Newly Diagnosed Primary Open-Angle Glaucoma
por: Tomić, Martina, et al.
Publicado: (2013)

Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension
por: Frenkel, Ronald EP, et al.
Publicado: (2007)

Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
por: Topouzis, Fotis, et al.
Publicado: (2019)

Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
por: Ruangvaravate, Ngamkae, et al.
Publicado: (2020)

Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2010)

The diurnal and nocturnal effects of travoprost in normal-tension glaucoma
por: Seibold, Leonard K, et al.
Publicado: (2014)

Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs
por: Lee, Susan S., et al.
Publicado: (2019)

In vitro effects of verteporfin on ocular cells
por: Ammar, David A., et al.
Publicado: (2013)

Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension
por: Tamçelik, Nevbahar, et al.
Publicado: (2017)

Lactones in the Synthesis of Prostaglandins and Prostaglandin Analogs
por: Tănase, Constantin, et al.
Publicado: (2021)

Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: Retrospective analysis of three medical/pharmacy claims databases
por: Schwartz, Gail F, et al.
Publicado: (2011)

Effect of audible and visual reminders on adherence in glaucoma patients using a commercially available dosing aid
por: Ho, Lawrence Y, et al.
Publicado: (2008)

Evaluation of adherence to morning versus evening glaucoma medication dosing regimens
por: Kahook, Malik Y, et al.
Publicado: (2007)

Ocular Surface Changes in Prostaglandin Analogue-Treated Patients
por: Shen, Wencui, et al.
Publicado: (2019)

Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs
por: Lo, Jonathan S, et al.
Publicado: (2016)

Glaucoma Surgery: How Do We Get from Here to There?
por: Kahook, Malik Y.
Publicado: (2009)

Prostaglandin analogs in ophthalmology
por: Subbulakshmi, S, et al.
Publicado: (2023)

Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension
por: Lee, Anne J, et al.
Publicado: (2010)

Efficacy and Safety of Switching from Prostaglandin Analog Therapy to Prostaglandin / Timolol Fixed Combination or Prostaglandin / Brimonidine Therapy
por: Inoue, Kenji, et al.
Publicado: (2017)

Association between meibomian gland dysfunction and compliance of topical prostaglandin analogs in patients with normal tension glaucoma
por: Lee, Tae Hee, et al.
Publicado: (2018)

Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
por: Mylla Boso, Ana Luiza, et al.
Publicado: (2020)

Quality of life of glaucoma patients under medical therapy with different prostaglandins
por: Guedes, Ricardo Augusto Paletta, et al.
Publicado: (2012)

Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells
por: Ammar, David A., et al.
Publicado: (2011)

New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma
por: Alviset, Gabriel, et al.
Publicado: (2022)

The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes
por: Tsikripis, Panagiotis, et al.
Publicado: (2013)

Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
por: Pérez-Roca, Fernando, et al.
Publicado: (2015)

Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis
por: Eyawo, Oghenowede, et al.
Publicado: (2009)

Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension
por: Lorenz, Katrin, et al.
Publicado: (2011)

Impact of minimally invasive glaucoma surgery on the ocular surface and quality of life in patients with glaucoma
por: Jones, Lee, et al.
Publicado: (2023)

Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2014)

Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma
por: Hommer, Anton, et al.
Publicado: (2015)

Ocular surface disease signs and symptoms of glaucoma patients and their relation to glaucoma medication in Finland
por: Parkkari, Minna, et al.
Publicado: (2022)

Interim Analysis of STREAMLINE(®) Surgical System Clinical Outcomes in Eyes with Glaucoma
por: Lazcano-Gomez, Gabriel, et al.
Publicado: (2022)

Ocular Surface Evaluation After the Substitution of Benzalkonium Chloride Preserved Prostaglandin Eye Drops by a Preservative-free Prostaglandin Analogue
por: LOPES, Nara Lidia Vieira, et al.
Publicado: (2019)

Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial
por: Fechtner, R D, et al.
Publicado: (2016)

Feasibility of motivational interviewing delivered by a glaucoma educator to improve medication adherence
por: Cook, Paul F, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6gr2qi5h0h6qp4e94la5psr9dc